Fresenius Medical Care Stock Today
| FMS Stock | USD 24.26 0.36 1.46% |
PerformanceOK
| Odds Of DistressLow
|
Fresenius Medical is selling for under 24.26 as of the 21st of March 2025; that is 1.46% down since the beginning of the trading day. The stock's lowest day price was 24.19. Fresenius Medical has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 19th of September 1996 | Category Healthcare | Classification Health Care |
KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical is traded on New York Stock Exchange in the United States. The company has 586.83 M outstanding shares of which 607.74 K shares are currently shorted by investors with about 2.56 days to cover. More on Fresenius Medical Care
Moving together with Fresenius Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Fresenius Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Board | FACHE MBA | ||||
| Thematic Idea | Healthcare (View all Themes) | ||||
| Old Names | [MIKROS SYSTEMS, Flinders Mines Ltd.] | ||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, Healthcare, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsFresenius Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Fresenius Medical's financial leverage. It provides some insight into what part of Fresenius Medical's total assets is financed by creditors.
| |||||
Fresenius Medical Care (FMS) is traded on New York Stock Exchange in USA. It is located in Else-Kröner-Strasse 1, Bad Homburg, Germany, 61352 and employs 111,513 people. Fresenius Medical is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 14.53 B. Fresenius Medical Care runs under Health Care Providers & Services sector within Health Care industry. The entity has 586.83 M outstanding shares of which 607.74 K shares are currently shorted by investors with about 2.56 days to cover.
Fresenius Medical Care has about 362.77 M in cash with 2.39 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.75.
Check Fresenius Medical Probability Of Bankruptcy
Ownership AllocationFresenius Medical holds a total of 586.83 Million outstanding shares. Roughly 93.0 percent of Fresenius Medical outstanding shares are held by general public with 7.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Fresenius Ownership Details
Fresenius Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Arrowstreet Capital Limited Partnership | 2024-12-31 | 205.5 K | |
| Abc Arbitrage Sa | 2024-12-31 | 186.2 K | |
| Old Mission Capital Llc | 2024-12-31 | 156.6 K | |
| Broyhill Asset Management, Llc | 2024-12-31 | 150.7 K | |
| Fmr Inc | 2024-12-31 | 147.2 K | |
| Marshall Wace Asset Management Ltd | 2024-12-31 | 129.6 K | |
| Quantinno Capital Management Lp | 2024-12-31 | 127.7 K | |
| Visionpoint Advisory Group, Llc | 2024-12-31 | 110.3 K | |
| Geode Capital Management, Llc | 2024-12-31 | 90.8 K | |
| Pzena Investment Management, Llc | 2024-12-31 | 15.3 M | |
| Fiduciary Management, Inc. Of Milwaukee | 2024-12-31 | 6.3 M |
Fresenius Medical Historical Income Statement
Fresenius Stock Against Markets
Fresenius Medical Corporate Management
| Charlotte Stange | VP Sustainability | Profile | |
| Roberto Fuste | Member of the Management Board for Asia-Pacific | Profile | |
| Pascale Witz | Independent Member of the Supervisory Board | Profile | |
| GailSuzanne Brown | Senior Development | Profile | |
| Katarzyna MazurHofsab | Management AG | Profile | |
| Borries Muller | Senior Communications | Profile |
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.